Status:
RECRUITING
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
University of Michigan
Medical University of South Carolina
Conditions:
Ventricular Tachycardia
Ischemic Cardiomyopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Over the last decade, radiofrequency catheter ablation (RFCA) has become an established treatment for ventricular arrhythmias (VA). Due to the challenging nature of visualizing lesion formation in rea...
Detailed Description
Over the last decade, radiofrequency catheter ablation (RFCA) has become an established treatment for ventricular arrhythmias (VA). RFCA uses electromagnetic energy that transforms into heat upon deli...
Eligibility Criteria
Inclusion
- Patient ≥ 18 y.o.
- Structural Heart Disease: Ischemic Cardiomyopathy
- Sustained Scar-related Monomorphic Ventricular Tachycardia documented by ECG or CIED interrogation
Exclusion
- If clinical ventricular arrhythmia is predominantly PVCs, supraventricular tachycardia, or ventricular fibrillation
- Myocardial infarction or cardiac surgery within 6 months
- Severe mitral regurgitation
- Stroke or TIA within 6 months
- Prior VT substrate ablation in the previous 6 months
- NYHA functional class IV
- Non-ischemic VT substrate
Key Trial Info
Start Date :
October 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 23 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06138873
Start Date
October 23 2024
End Date
November 23 2027
Last Update
September 22 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60614
2
Mass General Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
3
Medical University of Michigan
Ann Arbor, Michigan, United States, 48109
4
Mayo Clinic
Rochester, Minnesota, United States, 55905